Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Juan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8693-4271; OpenAlex author ID A5100446315. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 4

  1. HRASLS2 promotes the growth and glycolysis of pancreatic cancer by enhancing the stability of ASPH. Last author DOI 10.1007/s00210-025-04522-z↗
  2. Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical t… Co-author DOI 10.1007/s00262-024-03744-z↗
  3. Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic… Co-author DOI 10.3389/fonc.2022.782730↗
  4. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer… Co-author DOI 10.3892/or.2011.1595↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Du · 2 shared papers, 2022–2024 · strength 0.37
  2. Ying Ling · 1 shared paper, 2026 · strength 0.36
  3. Liang Qi · 1 shared paper, 2024 · strength 0.20
  4. Qin Wang · 1 shared paper, 2024 · strength 0.20
  5. Fan Tong · 1 shared paper, 2024 · strength 0.20
  6. Changchang Lu · 1 shared paper, 2022 · strength 0.16
  7. Xin Qiu · 1 shared paper, 2022 · strength 0.16
  8. Zhan Shi · 1 shared paper, 2022 · strength 0.16
  9. Baorui Liu · 1 shared paper, 2022 · strength 0.16
  10. Hui Zan · 1 shared paper, 2012 · strength 0.04
  11. Yingqiang Zhong · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.